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Rab5-dependent endosome fusion is sensitive to the phosphoinositide 3-kinase inhibitor,
wortmannin. It has been proposed that phosphoinositide 3-kinase activity may be
required for activation of rab5 by influencing its nucleotide cycle such as to promote its
active GTP state. In this report we demonstrate that endosome fusion remains sensitive
to wortmannin despite preloading of endosomes with stimulatory levels of a GTPase-
defective mutant rab5Q79L or of a xanthosine triphosphate-binding mutant, rab5D136N, in
the presence of the nonhydrolysable analogue XTPgS. These results suggest that activa-
tion of rab5 cannot be the principal function of the wortmannin-sensitive factor on the
endosome fusion pathway. This result is extrapolated to all GTPases by demonstrating
that endosome fusion remains wortmannin sensitive despite prior incubation with the
nonhydrolysable nucleotide analogue GTPgS. Consistent with these results, direct mea-
surement of clathrin-coated vesicle-stimulated nucleotide dissociation from exogenous
rab5 was insensitive to the presence of wortmannin. A large excess of rab5Q79L, beyond
levels required for maximal stimulation of the fusion assay, afforded protection against
wortmannin inhibition, and partial protection was also observed with an excess of
wild-type rab5 independent of GTPgS.
INTRODUCTION
An established cell-free assay of lumenal mixing be-
tween early endosomal compartments is thought to
principally reflect a homotypic membrane fusion
event (Gruenberg and Howell, 1987). In common with
other intracellular transport assays, it has been shown
to require the fusion factors N-ethylmaleimide sensi-
tive factor and a-SNAP (Diaz et al., 1989; Rodriguez et
al., 1994). Specificity of the fusion reaction may be due,
in part, to the small GTPase rab5, which has been
shown to localize to early endosomes (Chavrier et al.,
1991) and is required for the fusion reaction (Gorvel et
al., 1991). GTPases other than rab5, including ADP
ribosylation factor and trimeric G proteins, have also
been shown to influence endosome fusion (Colombo et
al., 1992; Lenhard et al., 1992), but as they are also
known to influence other trafficking steps, their role
may be less specific. We and others have recently
shown that a phosphoinositide (PI)1 3-kinase activity
is required for efficient endosome fusion (Jones and
Clague, 1995; Li et al., 1995; Spiro et al., 1996). On the
basis of experiments with a constitutively active form
of rab5 (Q79L mutant), it has been proposed that this
requirement for PI 3-kinase activity reflects an event
upstream of the activation of rab5 (Li et al., 1995).
The cycling of rab5 between cytosol and endosomes
and the associated nucleotide state of the enzyme have
been extensively studied. Upon translation, rab5 in
its GDP-bound form complexes with rab escort pro-
tein (REP-1). The REP-1/rab5 complex then interacts
with the heterodimeric rab geranylgeranyltransferase
(GGTase), which transfers a geranylgeranyl group to
cysteine residues at the rab5 C terminus (Alexandrov
‡Corresponding author.
1 Abbreviations used: CCV, clathrin-coated vesicle; GGTase, gera-
nylgeranyltransferase; GGPP, geranylgeranyl pyrophosphate;
HRP, horseradish peroxidase; PI, phosphoinositide; REP, rab
escort protein; TGN, trans-Golgi network; XTP, xanthosine 59-
triphosphate.
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et al., 1994). This modification is vital for rab5 activity
(Gorvel et al., 1991). After prenylation the GGTase
dissociates, and the prenylated REP–1/rab5 complex
can interact with endosomal membranes, whereupon
rab5 is transferred to the organelle (Alexandrov et al.,
1994). Subsequent to delivery to endosomes, a mem-
brane-associated exchange factor facilitates the ex-
change of GDP for GTP (Ullrich et al., 1994), producing
the active form of rab5 (Stenmark et al., 1994). Hydro-
lysis of GTP returns rab5 to the GDP form, which can
be extracted from the membrane by guanine nucleo-
tide dissociation inhibitor, a protein homologous to
REP-1 (Ullrich et al., 1993). Subsequently, both associ-
ation with and dissociation from endosomes of preny-
lated-rab5 can be mediated by guanine nucleotide dis-
sociation inhibitor.
Elegant studies by Rybin et al. have shown that an in
vitro endosome fusion assay could be configured such
that it is dependent on a recombinant rab5 mutant,
rab5D136N, that binds xanthosine 59-triphosphate
(XTP) rather than GTP (Rybin et al., 1996). Fusion was
dependent on exchange of xanthosine 59-diphosphate
(XDP) for XTP but not XTP hydrolysis.
There is a growing catalogue of evidence for a role
of PIs as mediators of membrane-trafficking events.
Particular attention has focused on the generation of
PI 3-phosphates mediated by PI 3-kinases since the
Saccharomyces cerevisiae VPS34 gene, implicated in traf-
fic from the trans-Golgi network (TGN) to the vacuole,
was shown to be a PI 3-kinase (Schu et al., 1993). The
study of PI 3-kinase function in mammalian mem-
brane traffic has recently been facilitated by the avail-
ability of specific inhibitors of PI 3-kinases, wortman-
nin and LY294002 (Arcaro and Wymann, 1993; Vlahos
et al., 1994). In addition to endosome fusion, a role for
PI 3-kinase in a multitude of membrane trafficking
steps has been demonstrated, including fluid phase
endocytosis (Clague et al., 1995; Li et al., 1995), TGN to
lysosomal transport (Brown et al., 1995; Davidson,
1995), and PDGF receptor trafficking (Joly et al., 1995).
A number of mammalian PI 3-kinases that have dif-
ferent substrate preferences and are regulated differ-
ently have now been cloned and sequenced, but all
display sensitivity to wortmannin (Zvelebil et al.,
1996), such that the role of individual enzymes is not
easy to assess.
Wortmannin and LY294002 inhibit endosome fusion
(Jones and Clague, 1995; Li et al., 1995; Spiro et al.,
1996) whilst insect cell cytosol overexpressing p110a
PI 3-kinase catalytic subunit enhances endosome fu-
sion relative to control cytosol (Li et al., 1995). Most
interestingly, when a GTPase-deficient mutant
rab5Q79L was included in an assay of fusion between
endosomes derived from J774 macrophages, sensitiv-
ity to wortmannin was completely lost (Li et al., 1995).
As the Q79L mutant of rab5 is deficient in GTP hy-
drolysis, it is trapped in the GTP bound form or “on
state”; this suggests that a PI 3-kinase activity may
directly or indirectly promote the activity of a factor
that influences the nucleotide cycle of rab5 to increase
the proportion of rab5 in the GTP bound form either
by enhancing guanine nucleotide exchange or inhibit-
ing GTPase activity. Thus the Q79L mutation would
overcome this requirement and render the assay in-
sensitive to PI 3-kinase inhibition.
In this paper we have extended the studies of Li et al.
(1995), on the relationship between the wortmannin-
sensitive factor and rab5 with respect to endosome
fusion. Our results do not rule out a direct effect of
wortmannin on the nucleotide cycle of rab5; however,
they strongly suggest that this cannot be the primary




Monoclonal rab5 antibody 4F11 was from Dr A. Wandinger-Ness
(Department of Biochemistry, Molecular Biology and Cell Biology,
Northwestern University, Chicago, IL). Wortmannin, geranylgera-
nyl pyrophosphate (GGPP), XDP, XTP, and GTPgS were from
Sigma. Wortmannin was prepared immediately before use in ap-
propriate buffer from a 1 mM stock solution in dimethylsulfoxide.
XTPgS was prepared by the method of Goody et al. (1972). [3H]-GDP
25Ci/mmol was from DuPont NEN (Wilmington, DE).
Cell Culture
Reagents were from Life Technologies (Gaithersburg, MD). Baby
hamster kidney cells (BHK-21) were grown on 10-cm diameter Petri
dishes in Glasgow minimal essential medium (BHK 21) media sup-
plemented with 5% vol/vol fetal bovine serum, 100 U/ml penicil-
lin/streptomycin, 10% vol/vol tryptose phosphate broth.
Expression and Purification of Recombinant
Proteins
REP-1 and heterodimeric rab-GGTase complex were purified from
baculovirus-infected Sf9 cells as described previously (Alexandrov
et al., 1994; Andres et al., 1993; Cremers et al., 1990). His6-tagged
wild-type rab5, rab5Q79L, and rab5D136N plasmids were introduced
into Escherichia coli strain BL21, and the proteins were purified as
described by Nuoffer et al. (1995). GDP was replaced with XDP
during rab5D136N purification.
Preparation of Posttranslationally Modified rab5/
REP-1 Complex
The method was essentially as described previously (Alexandrov et
al., 1994). Briefly, 10.9 mM of his6 rab5, his6 rab5D136N, or his6
rab5Q79L was incubated with 2 mM rabGGTase, 3 mM REP-1, and 60
mM GGPP for 15 min at 30°C in (20 mM HEPES-KOH, pH 7.2, 20
mM NaCl, 2 mM dithiothreitol (DTT), 2 mM MgCl2, 0.005% [wt/
vol] Triton X-100). The samples were then diluted 120-fold in REP-1
complex buffer (25 mM Tris, pH 7.9, 50 mM KCl, 5 mM MgCl2, 1
mM DTT) and concentrated in a Microcon 10 microconcentrator
(Amicon, ) before storage at 270°C.
Early Endosome Fusion Assay
The experiments were carried out essentially as described previ-
ously (Clague et al., 1994; Gorvel et al., 1991). Briefly, confluent
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BHK-21 cells grown on 10-cm diameter Petri dishes were washed
with 37°C phosphate-buffered saline, pH 7.4. Subsequently, either 4
mg/ml avidin or 1.8 mg/ml biotinylated horseradish peroxidase
(HRP) in Dulbecco’s phosphate-buffered saline supplemented with
1 mM CaCl2 and 1 mM MgCl2 were incubated with the cells for 9
min at 37°C. This incubation was followed by extensive washing at
4°C before removal of cells from the dish with a cell scraper and
homogenization in homogenization buffer (3 mM imidazole/HCl
pH 7.4, 250 mM sucrose, 1 mg/ml pepstatin, 2 mg/ml aprotinin, 2
mg/ml leupeptin) by several passages through a 23-gauge needle.
Postnuclear supernatants were obtained by centrifugation at
1,500 3 g for 15 min.
Postnuclear fractions containing avidin or biotin-HRP–loaded en-
dosomes were then combined in a mixture (total volume 217 ml)
containing 10 mM HEPES-KOH, pH 7.0, 1.2 mM MgCl2, 50 mM
KOAc, 0.8 mM DTT, biotin-insulin (to quench any free avidin) and
ATP-regenerating system, to which had been added the various
factors used in this study. This mixture was then incubated at 37°C
for the indicated times. Alternatively, postnuclear supernatants con-
taining avidin or biotin-HRP–labeled early endosomes were ali-
quoted and separately preincubated for 10 min at 37°C with the
described factors. Preincubations were performed in the absence of
ATP-regenerating system and salts. In all procedures the appropri-
ate buffer was used to substitute volume additions of added re-
agents. Further particulars of specific experiments are given in the
figure legends. The samples were then placed on ice before mixing
in fusion assays as above. Fusion assays were stopped by lysis on ice
for 15 min with 0.25% wt/vol Triton X-100. Fusion results in the
formation of an avidin–biotin–HRP complex, which was immuno-
precipitated with anti-avidin antibodies bound to protein A sepha-
rose. The relative amounts of immunoprecipitated HRP were quan-
tified by determination of the HRP activity with o-dianisidine as
substrate.
Rab5 Binding to Postnuclear Supernatant
Membranes
BHK-21 postnuclear supernatants without internalized markers
were prepared as above. REP-1/rab5Q79L or REP-1/wild type rab5
complex were centrifuged at 115,000 3 g for 2 min at 2°C to remove
aggregates. Postnuclear supernatants (60 ml) containing 330 mg of
total protein and 100 mM GTP or 60 mM GTPgS were incubated in
the absence or presence of 50–1000 nM REP-1/rab5Q79L or REP-1/
wild-type rab5 complex, respectively, for 10 min before addition of
203 sample volume of ice-cold wash buffer (12.5 mM HEPES, pH
7.2, 75 mM KOAc, 1 mM MgOAc, 1 mM DTT, 5 mM MgCl2) and
centrifugation at 150,000 3 g for 10 min at 4°C. The pellets were
washed with wash buffer, and the solutions were centrifuged at
115,000 3 g for 5 min at 4°C. The supernatants were aspirated, and
the pellets were resuspended in SDS electrophoresis sample buffer.
Rab5 was determined by Western blotting.
Assay for Dissociation of [3H]GDP from rab5
Stimulated by Clathrin-coated Vesicles (CCVs)
Rat brain CCVs were purified by differential centrifugation as de-
scribed by Maycox et al. (1992) and resuspended in 0.1 M 2-(N-
morpholino)ethanesulfonic acid, pH 6.5, 0.5 mM MgCl2, 1 mM
EGTA, 1 mM DTT. The assay method is essentially as described by
Horiuchi et al. (1995). REP-1/[3H]GDP–rab5 complex was prepared
by incubating purified his6 rab5 (0.2 mM) with [3H]GDP (5 mM) in 20
mM HEPES/KOH, pH 7.2, 10 mM EDTA, 5 mM MgCl2,1 mM DTT
for 30 min at 30°C. The solution was placed on ice and adjusted to
20 mM MgCl2. [3H]GDP-rab5 (1.25 mM) was then incubated with
GGTase (0.82 mM), REP-1 (1.24 mM), and GGPP (50 mM) in 20 mM
HEPES/KOH, pH 7.2, 20 mM NaCl, 0.0048% (wt/vol) Triton X-100,
1 mM DTT for 20 min at 30°C before passing the solution through
a Biospin 6 column (Bio-Rad, Richmond, CA) equilibrated with 20
mM HEPES/KOH, pH 7.2, 20 mM NaCl, 5 mM MgCl2, 1 mM DTT,
0.005% (wt/vol) Triton X-100.
REP-1/[3H]GDP–rab5 complex (100 nM, 20,000 cpm) was incu-
bated at 30°C with CCVs (1 mg/ml) in 0.1 M 2-(N-morpholino)eth-
anesulfonic acid, pH 6.5, 1 mM EGTA, 5 mM MgCl2, 5 mM GTP, 1
mM DTT for the various times indicated in Figure 8. The reactions
were stopped by addition of 63 sample volume of ice-cold 20 mM
HEPES/KOH, pH 7.2, 100 mM NaCl, 25 mM MgCl2 and immedi-
ately loaded on presoaked 0.45 mM HA filters (Millipore, Bedford,
MA) to which a vacuum was then applied. The filters were washed
with 50 ml of the same buffer before scintillation counting.
RESULTS
Geranylgeranylated Rab5D136N was preloaded onto
avidin- and biotin-HRP–containing endosomes before
they were combined in a fusion incubation. In the
absence of XTP or XTPgS, addition of this mutant
exerts a dominant negative effect on the endosome
fusion assay (Figure 1a) as previously observed by
Rybin et al. (1996). The degree of inhibition of endo-
some fusion is very similar to that obtained by appli-
cation of the PI 3-kinase inhibitor wortmannin, and no
further inhibition is observed by combining the mu-
tant protein and wortmannin in the assay. Fusion
activity in the presence of this XTP-binding mutant
can be restored and stimulated beyond control levels
by the addition of XTP (not shown) or the nonhydro-
lysable analogue XTPgS. In the presence of XTPgS, the
major part of the fusion signal is therefore contingent
on the presence of this nucleotide (Figure 1a), which
will trap exogenously added rab5 in an activated state.
The fusion signal after preincubation of components
with REP-1/rab5D136N and XTPgS was still substan-
tially inhibited by wortmannin (Figure 1a). This exper-
iment is very suggestive that the influence of wort-
mannin on endosome fusion is exerted through a
means other than a postulated effect on the rab5 nu-
cleotide cycle. The dose response of the fusion assay to
wortmannin was found to be very similar for endo-
some fusion under control conditions and for XTPgS-
dependent fusion (Figure 1b). The concentration range
over which wortmannin inhibition is observed
(IC50,50 nM) is consistent with the well characterized
inhibition of PI 3-kinases by this drug (Wymann et al.,
1996).
We next repeated the endosome fusion assay under
the same conditions except that the GTPase-deficient
mutant rab5Q79L was loaded onto membranes (Figure
2). By virtue of its poor ability to hydrolyze GTP, this
rab5 mutant is trapped in the active GTP state and,
like XTPgS in the preceding experiment, is predicted
to render the assay insensitive to factors that regulate
the nucleotide cycle of rab5. The fusion assay was
stimulated by addition of rab5Q79L, yet this stimulated
fusion was substantially sensitive to wortmannin (Fig-
ure 2) with a similar dose response to fusion driven by
endogenous rab5. This result is surprising because Li
et al. (1995) have convincingly shown that rab5Q79L
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renders an assay of fusion between macrophage en-
dosomes insensitive to wortmannin. In each of our
experiments (Figures 1 and 2) however, it is noticeable
that the activated mutant proteins, even in the pres-
ence of wortmannin, retain some stimulatory activity
relative to control incubations.
This observation prompted us to vary the concen-
tration of exogenous REP/rab5Q79L complex we
added to the system and thereby the amount of
rab5Q79L delivered to membranes. We observed that at
high concentrations of REP-1/rab5Q79L, we could re-
produce the observation of Li et al., in that the fusion
signal becomes insensitive to the presence of wort-
mannin (Figure 3a). It is noteworthy that the concen-
Figure 1. Wortmannin inhibition of XTPgS-REP-1d136n-dependent
early endosome fusion. (a) Postnuclear supernatants containing avi-
din- or biotin-HRP–loaded early endosomes were aliquoted and
separately preincubated at 37°C for 10 min with REP-1 complex
buffer (A and B); 100 nM REP-1/rab5D136N (C and D); 100 nM
REP-1/rab5D136N, 0.5 mM XTPgS (E and F). Correspondingly
treated avidin- or biotin-HRP–containing fractions were then com-
bined in a standard fusion assay and incubated at 37°C for 30 min
in the presence (B, D, and F) or absence (A, C, and E) of 100 nM
Figure 2. Early endosome fusion is stimulated by REP-1/rab5Q79L
but remains sensitive to inhibition by wortmannin. Postnuclear
supernatants containing 100 mM GTP and either avidin- or biotin-
HRP–loaded early endosomes were aliquoted and separately incu-
bated for 10 min at 37°C with REP-1 complex buffer (h) or 200 nM
REP-1/rab5Q79L (F). Correspondingly treated avidin- or biotin-
HRP–containing fractions were then combined in a standard fusion
assay and incubated at 37°C for 30 min with the indicated concen-
trations of wortmannin.
Figure 1 (cont). wortmannin. (b) Postnuclear supernatants con-
taining avidin- or biotin-HRP–loaded early endosomes were ali-
quoted and separately preincubated for 10 min at 37°C with REP-1
complex buffer (h) or 100 nM REP-1/rab5D136N,0.5 mM XTPgS(F).
Correspondingly treated avidin- or biotin-HRP–containing frac-
tions were then combined in a standard fusion assay and incubated
at 37°C for 30 min with the indicated concentrations of wortmannin.
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trations of rab5Q79L required for full protection from
wortmannin are significantly higher than those re-
quired for maximal stimulation of the fusion assay.
Figure 3b illustrates the association of exogenous rab5
with membranes at the end of the preincubation pe-
riod. Even at the lowest concentrations used, the level
of membrane-associated rab5Q79L is many fold that of
endogenous levels of rab5. In BHK cells, about 20% of
endogenous membrane-associated rab5 is in the GTP
state at any one time (Stenmark et al., 1994). If the
primary action of wortmannin was to reduce the num-
ber of rab5 molecules in the GTP state, for example by
inhibiting nucleotide exchange, then we would expect
full protection from wortmannin by loading an equal
number of rab5Q79L molecules that will accumulate in
the GTP form. In fact, Figure 3 shows that we can add
back a much larger number of rab5Q79L molecules than
the highest conceivable number of GTP-bound wild-
type rab5 molecules present in control conditions and
still retain significant sensitivity to wortmannin. Den-
sitometric analysis of an enhanced chemiluminescence
(ECL)-developed Western blot (Figure 3b) indicates a
5- to 10-fold excess of membrane-associated his6-
rab5Q79L over endogenous wild-type rab5, at the low-
est concentration of REP-1/rab5Q79L that we have
used (50 nM). This result is inconsistent with the hy-
pothesis that the primary effect of wortmannin is to
influence the nucleotide state of rab5.
The rab5D136N mutation allowed us to selectively
activate rab5-dependent fusion with XTPgS (Figure 1).
We also conducted an experiment in which we used
GTPgS to preactivate all GTPase proteins in the fusion
incubation mixture including endogenous rab5 (Fig-
ure 4). We obtained similar results to those when
rab5D136N alone is activated (Figure 1), i.e., the fusion
assay remained substantially sensitive to wortmannin,
despite the presumed entrapment of all GTPases in
their active state. This result suggests that the require-
ment of endosome fusion for PI 3-kinase activity is not
upstream of the activation of any GTPase.
In the way that we configured our standard assay,
fractions were preincubated with nonhydrolysable
nucleotide in the absence of wortmannin for 10 min
before the fusion incubation. It could be argued that
this is insufficient time for enough nucleotide ex-
change on the relevant GTPase to take place and that
the subsequent addition of wortmannin imposes an
absolute block on further exchange. Arguing against
this, it is fair to say that most GTPases will undergo
exchange on this time scale; for example .80% nucle-
otide exchange took place within 10 min for rab5D136N
loaded onto BHK cell-derived membranes (Rybin et
al., 1996). Furthermore, in the study of Li et al. (1995),
wortmannin was added to the system before addition
of rab5Q79L. As rab5 associates with membranes in the
GDP state (Alexandrov et al., 1994; Ullrich et al., 1994),
but nevertheless they observed rab5Q79L-dependent
recovery from the wortmannin block, a significant
amount of GTP association with rab5Q79L must have
taken place in the presence of wortmannin, during the
course of the assay. We conducted an experiment in
which we systematically varied the point at which
GTPgS was added, during a constant 20-min preincu-
bation period (Figure 4b). We found no evidence that
an increased time of preincubation with GTPgS led to
increased protection from wortmannin inhibition (Fig-
ure 4b).
The rate-limiting event for nucleotide exchange is
nucleotide dissociation. We prepared REP-1/
[3H]GDP–rab5 complex and presented it to purified
CCVs. We observed a CCV-dependent stimulation of
nucleotide dissociation, similar to that previously ob-
Figure 3. Increasing membrane concentrations of rab5Q79L protects
early endosome fusion from wortmannin inhibition. (a) Postnuclear
supernatants containing avidin- or biotin-HRP–loaded early endo-
somes were separately preincubated for 10 min at 37°C with 100 mM
GTP and 0, 50, 200, 500, or 1000 nM REP-1/rab5Q79L. Correspond-
ingly treated avidin or biotin-HRP containing fractions were then
combined in a standard fusion assay and incubated at 40 min at
37°C in the presence (h) or absence (F) of wortmannin (100 nM). (b)
Postnuclear supernatants were incubated as in Figure 5a. The sam-
ples were centrifuged and 13 mg of the pelleted fraction were loaded
on a 13% SDS-PAGE gel. Rab5 was detected by enhanced chemilu-
minescence Western blotting using a rab5 monoclonal antibody. The
position of BHK-21 rab5 and his6-rab5Q79L is shown.
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served by Horiuchi et al. (1995), which was indepen-
dent of wortmannin (Figure 5).
Incubation with GTPgS offers a modest stimulation
of fusion (Figure 4). We reasoned that this may be
mediated through rab5, similar to the observation
with XTPgS (Figure 1), such that if we increased the
level of wild-type rab5 in the system, GTPgS-depen-
dent rescue from wortmannin treatment may be ob-
served. This is analogous to increasing amounts of
rab5Q79L in the system that we have shown leads to
recovery from wortmannin inhibition in a concentra-
tion-dependent manner (Figure 3). Membrane loading
of wild-type rab5 in the presence of GTPgS was less
efficient than rab5Q79L but was nevertheless many fold
higher than native BHK rab5 (Figure 6b). We found
Figure 4. Early endosome fusion is stimulated by GTPgS but is
still sensitive to inhibition by wortmannin. (a) Postnuclear superna-
tants containing avidin- or biotin-HRP–loaded early endosomes
were separately preincubated for 10 min at 37°C without (A and B)
or with (C and D) 40 mM GTPgS. Correspondingly treated avidin- or
biotin-HRP–containing fractions were then combined in a standard
fusion assay supplemented with buffer (A and C) or 100 nM wort-
mannin (B and D) and incubated for 30 min at 37°C. (b) Postnuclear
supernatants containing avidin- or biotin-HRP–loaded early endo-
somes were separately preincubated for various periods of time (Dt)
at 37°C with 40 mM GTPgS. Correspondingly treated avidin- or
biotin-HRP–containing fractions were then combined in a standard
Figure 5. The stimulation of [3H]GDP dissociation from rab5 by
CCVs is not affected by wortmannin. REP-1/[3H]GDP–rab5 (100
nM) was incubated in the absence (F) or presence (,) of 1 mg/ml
CCVs for the indicated periods of time in the absence () or pres-
ence () of 200 nM wortmannin. At the end of the reaction the
samples were loaded on filters and protein-bound radioactivity was
quantified as described in MATERIALS AND METHODS. The data
represent the mean values from two independent experiments of
filter- associated counts expressed relative to counts measured be-
fore incubation.
Figure 4 (cont). fusion assay in the absence (•) or presence (▫) of
100 nM wortmannin and incubated for 30 min at 37°C. The percent-
age inhibition of the fusion assay signal for each condition is also
plotted (, dashed line).
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rab5-dependent stimulation of both control and wort-
mannin-treated signals in the presence of GTPgS (Fig-
ure 6a), although in a total of three experiments, we
were never able to completely overcome wortmannin
inhibition as observed for rab5Q79L (Figure 3). Surpris-
ingly, we obtained very similar results when wild-
type rab5 was added to the assay in the absence of
GTPgS (Figure 6c), suggesting that the amount of rab5
bound to membranes is the crucial factor for overcom-
ing wortmannin inhibition of endosome fusion.
DISCUSSION
Effects on Nucleotide Hydrolysis Do Not Explain
Wortmannin Inhibition
The demonstration that an XTP-binding mutant of
rab5 (D136N) behaves as the wild-type protein, except
in the matter of nucleotide preference, has provided
an important tool for functional studies of this protein
(Rybin et al., 1996). XTP is not produced naturally, so
the addition of exogenous XTP achieves a specific
activation of rab5 that cannot be achieved for the wild-
type rab5 with GTP, because of the large number of
other GTP-binding proteins in the system. We have
delivered XDP-rab5D136N to the endosomal membrane
after geranylgeranylation of the recombinant protein
in a complex with REP-1 and subsequent presentation
of REP-1/prenylated rab5 complex to membrane frac-
tions. We have observed qualitatively similar effects
on an in vitro assay of endosome fusion to those
reported by Rybin et al. (1996). In the absence of XTP
the mutant exerts a dominant negative effect on endo-
some fusion, and addition of XTP or the nonhydrolys-
able analogue XTPgS stimulates endosome fusion
above control levels obtained in the absence of exog-
enous rab5 (Figure 1a). As the major component of the
fusion signal is inhibited by exogenous rab5D136N in
the absence of XTP, it is clear that the fusion signal
produced by inclusion of XTPgS is mediated through
rab5. We clearly show that rab5-dependent endosome
Figure 6. Increasing membrane concentrations of his6 rab5 with or
without GTPgS partially protect early endosome fusion from wort-
mannin inhibition. (a) Postnuclear supernatants containing avi-
Figure 6 (cont). din- or biotin-HRP—loaded early endosomes
were separately preincubated for 10 min at 37°C with 60 mM GTPgS
and 0, 50, 200, 500, or 1000 nM REP-1/rab5. Correspondingly
treated avidin or biotin-HRP—containing fractions were then com-
bined in a standard fusion assay for 40 min at 37°C in the presence
(h) or absence (F) of wortmannin (100 nM). (b) Postnuclear super-
natants were incubated as in Figure 6a. The samples were centri-
fuged and 13 mg of the pelleted fractions were loaded on a 13%
SDS-PAGE gel. Rab5 was detected by Western blotting using a rab5
monoclonal antibody. The position of BHK-21 rab5 and his6-tagged
native rab5 is shown. (c) Postnuclear supernatants containing avi-
din- or biotin-HRP—loaded early endosomes were separately pre-
incubated without added nucleotide for 10 min at 37°C with 0,50,
200, 500, or 1000 nM REP-1/rab.5 Correspondingly treated avidin or
biotin-HRP containing fractions were then combined in a starndard
fusion assay for 40 min at 37°C in the presence (h) or absence (F) of
wortmannin (100 nM).
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fusion is inhibited by the PI 3-kinase inhibitor wort-
mannin, in agreement with previous results (Jones
and Clague, 1995; Li et al., 1995; Spiro et al., 1996). It is
important to note that in this experiment, exogenous
rab5 and XTPgS are preincubated with postnuclear
supernatant fractions in the absence of ATP before
exposure with wortmannin. As we have used a non-
hydrolysable analogue of XTP to elicit rab5-dependent
fusion, the inhibitory action of wortmannin cannot be
the result of stimulation of nucleotide hydrolysis by
rab5. This result is confirmed by the fact that we also
see wortmannin inhibition of fusion in the presence of
a GTPase-deficient mutant of rab5 (Q79L) at similar
concentrations (Figure 2). Finally, this result can be
extrapolated to all GTP-binding proteins in the fusion
incubation, as wortmannin is also shown to inhibit
endosome fusion in the presence of GTPgS (Figure 4).
Effects on Nucleotide Exchange Do Not Explain
Wortmannin Inhibition
Inhibition of endosome fusion by wortmannin could
be due to a reduction in nucleotide exchange on rab5
(or another GTPase) that would lead to less protein in
the GTP form. PI-3 kinase activity is known to stimu-
late the nucleotide exchange rate of the small GTPase
rac (Hawkins et al., 1995) and of rab4 in adipocytes
(Shibata et al., 1997). However, this attractive hypoth-
esis is contraindicated by the fact that for experiments
that were carried out with nonhydrolysable nucleo-
tide analogues (Figures 1 and 4), fractions were pre-
incubated with these analogues for 10 min at 37°C,
allowing time for nucleotide exchange before combi-
nation in a fusion assay and exposure to wortmannin.
Nevertheless, we still observed inhibition of fusion by
wortmannin. Furthermore, the time of preincubation
with GTPgS (up to 20 min) had no effect on the fusion
signal observed with wortmannin (Figure 4b). We also
made a direct measurement of the rate-limiting event
in nucleotide exchange on rab5, i.e., nucleotide disso-
ciation, in the presence of CCV- coated vesicles. Al-
though it is not certain that this CCV-associated stim-
ulatory activity is the same as that on early
endosomes, the stimulated dissociation of nucleotide
was unaffected by the presence of wortmannin (Figure
5), consistent with our other observations.
High Levels of rab5Q79L Mutant Overcome
Wortmannin Inhibition
Li et al have shown previously that rab5Q79L mutant,
which is deficient in GTP hydrolysis, can render an
endosome fusion assay insensitive to the presence of
wortmannin (Li et al., 1995). We were surprised by our
observation that we could retain significant sensitivity
to wortmannin even after addition of stimulatory lev-
els of rab5Q79L (Figure 2) in apparent contradiction to
the results of Li et al. We were able to resolve this
contradiction by adding even higher levels of rab5Q79L
to the assay, which rendered it insensitive to wort-
mannin (Figure 3a). It is important to note that there
are significant differences in the experimental setup of
these two studies, notably in the endosome-labeling
procedure, the type of cells used, and the methods by
which prenylated rab5 is produced and delivered to
endosomes. Nevertheless, there is a convergence in
the findings of both studies. The concentration of ex-
ogenous rab5 added to the assay by Li et al. corre-
sponds to a final concentration of 700 nM, similar to
that which we have found to be required for complete
recovery (Figure 3). From our results (Figure 3), it is
clear that endosome fusion does not absolutely require
PI 3-kinase activity if there is enough GTP-bound rab5
in the system, but also that the requirement for this
activity when only endogenous levels of rab5 are
present is not simply to promote the GTP-bound state
of rab5 (see preceding discussion). The levels of
rab5Q79L that must be added to the system for protec-
tion from wortmannin far exceed the highest conceiv-
able amount of native rab5 present that could be in-
directly inactivated by wortmannin. Of course, this
does not rule out the possibility that wortmannin may
directly or indirectly influence the nucleotide cycle of
rab5, but suggests that this cannot be its primary role
in endosome fusion.
The fact that rab5Q79L can prevent a wortmannin
block argues against the requirement for PI 3-kinase
lying downstream of rab5 on the fusion pathway. We
suggest that, taken all together, these results are most
easily explained if PI 3-kinase activity generates or
regulates an accessory factor that acts in concert with
rab5. We have found conditions for which endosome
fusion is effectively stimulated due to enhanced levels
of active rab5, yet for which inhibition is still observed
with a similar dose response to control conditions
(Figures 1 and 2). This may be expected if PI 3-kinase
activity is required at a different step on the fusion
pathway to rab5 but will also occur if its product
governs an equilibrium reaction with a high-power
dependence on its concentration. For example, the
creation of a lipid microdomain may depend on the
cooperation of many lipid molecules of a particular
type.
We have also shown that, in our hands, high levels
of wild-type rab5 are able to promote fusion in the
presence of wortmannin. The presence of GTPgS had
no significant supplementary effect on wild-type rab5-
mediated prevention of a wortmannin block. We were
not able to obtain complete protection as in the case of
rab5Q79L, but this may reflect the lower degree of
membrane loading that we were able to achieve (com-
pare Figures 3b and 6b). This observation is opposite
to that made by Li et al. who saw no rescue from
wortmannin inhibition by adding wild-type rab5 to
their assay. Differences between the two assay systems
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that could underlie this discrepancy have already been
outlined above.
The major function of rab proteins is believed to be
the promotion of interaction between cognate v- and
t-SNAREs, which mediate binding between compart-
ments destined to fuse. The strongest evidence for this
idea comes from studies of endoplasmic reticulum to
Golgi transport in the yeast S. cerivisiae which have
shown that mutations in the rab protein YPT1 prevent
assembly of the relevant SNARE complex. It has re-
cently been proposed that the role of YPT1 is to dis-
place a negative regulator of SNARE complex assem-
bly, SLY1, from interacting with the t-SNARE Sed5p,
by virtue of a direct transient interaction with Sed5p
(Lupashin and Waters, 1997). As most intracellular
fusion events (from yeast to man) are presumed to use
the same basic design, it is attractive to suppose that
rab5 engages in similar interactions, although hard
evidence is currently lacking. Furthermore, as phospha-
tidylinositols have been shown to be ubiquitous reg-
ulators of protein–protein interactions, it may be that
PI 3-kinase activity is required to generate phosphor-
ylated lipids that promote rab5 interaction with a t-
SNARE or other effector protein. An excess of rab5
may overcome this requirement by a mass action ef-
fect. This is frequently observed for nonessential ele-
ments of a membrane transport reaction, e.g., dele-
tions in a rab gene in yeast (YPT1) can be overcome by
increasing the cellular concentration of v-SNAREs re-
quired at the same transport step (Dascher et al., 1991;
Ossig et al., 1991).
Concluding Remarks
PI 3-kinase activity clearly influences rab5-dependent
events in a number of cell lines. However, this is
unlikely to be a conserved feature of rab protein-
dependent mechanisms. Transport through the bio-
synthetic pathway is insensitive to wortmannin, yet
dependent on rab proteins. Moreover, the rab9-depen-
dent transport of cation-independent mannose
6-phosphate receptor from late endosomes to the TGN
is insensitive to wortmannin (Nakajima and Pfeffer,
1997). In adipocytes, insulin stimulation of PI 3-kinase
activity influences the subcellular localization of rab4
(Cormont et al., 1996) and the nucleotide exchange on
this protein (Shibata et al., 1997), whereas insulin-
induced rab5 movement is wortmannin insensitive.
Rab5 may be different from most other rab proteins
by virtue of participating in signal transduction cas-
cades initiated at the plasma membrane. Activated ras
has been shown to increase fluid phase endocytosis,
and this stimulation is abolished by a dominant neg-
ative mutant of rab5 (Li et al., 1997). Activated ras has
also previously been shown to interact with PI 3-ki-
nase (Rodriguez-Viciana et al., 1996). Interestingly, the
tumor suppressor, tuberin, has recently been identi-
fied as a candidate protein for regulating rab5 activity
(Xiao et al., 1997). The characterization of these inter-
actions is an important task for the future, as recipro-
cal relationships between signal transduction and
membrane trafficking emerge as a theme of study.
Toward this goal, our results indicate that the effects of
wortmannin on a rab5-dependent event cannot be
accounted for by any effect on the nucleotide cycle of
rab5.
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